JPH04256434A - Pyrogen adsorbent - Google Patents
Pyrogen adsorbentInfo
- Publication number
- JPH04256434A JPH04256434A JP3103228A JP10322891A JPH04256434A JP H04256434 A JPH04256434 A JP H04256434A JP 3103228 A JP3103228 A JP 3103228A JP 10322891 A JP10322891 A JP 10322891A JP H04256434 A JPH04256434 A JP H04256434A
- Authority
- JP
- Japan
- Prior art keywords
- silica gel
- pyrogen
- amino
- adsorbent
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002510 pyrogen Substances 0.000 title claims abstract description 19
- 239000003463 adsorbent Substances 0.000 title claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000741 silica gel Substances 0.000 claims abstract description 15
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 15
- 125000001165 hydrophobic group Chemical group 0.000 claims abstract description 12
- 125000003277 amino group Chemical group 0.000 claims description 16
- 239000011148 porous material Substances 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 239000007924 injection Substances 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 3
- 239000006087 Silane Coupling Agent Substances 0.000 abstract description 2
- 238000000502 dialysis Methods 0.000 abstract description 2
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 230000002745 absorbent Effects 0.000 abstract 1
- 230000027950 fever generation Effects 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 11
- -1 infusions Substances 0.000 description 10
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BVBBZEKOMUDXMZ-UHFFFAOYSA-N n,n-diethyl-3-triethoxysilylpropan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCN(CC)CC BVBBZEKOMUDXMZ-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 239000000385 dialysis solution Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- OYKVBBRFUUSASW-UHFFFAOYSA-N 2-[benzyl(diethoxy)silyl]oxyethanamine Chemical compound NCCO[Si](OCC)(OCC)CC1=CC=CC=C1 OYKVBBRFUUSASW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005245 sintering Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 101150054171 thf1 gene Proteins 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、注射、人工透析等によ
り生体内に投与または溶出混入された場合に発熱を誘発
する物質、即ち発熱物質(パイロジェン)の除去に有効
な吸着剤に関する。さらに詳しくは、注射液、輸液、透
析液等に混入している発熱物質の吸着除去剤に関するも
のである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an adsorbent effective for removing a pyrogen, a substance that induces heat generation when administered or eluted into a living body by injection, artificial dialysis, etc. More specifically, the present invention relates to an adsorption/removal agent for pyrogens contained in injection solutions, infusions, dialysates, and the like.
【0002】0002
【従来の技術】現在発熱物質として問題になっているの
は、大腸菌等のグラム陰性細菌の細胞壁由来のリポポリ
サッカライド(LPS)であることがわかっている。発
熱物質の除去に関しては種々の研究がなされており、活
性炭、イオン交換樹脂、各種分離膜による除去が試みら
れているが未だ実用の域には達していない。即ち、これ
らの吸着剤ではパイロジェンの選択性が低く、また吸着
除去量も満足のいく値は得られていない。さらに吸着剤
合成過程の不純物溶出の問題もあって実際に用いること
はできないのが現状である。BACKGROUND OF THE INVENTION It has been found that lipopolysaccharide (LPS), which is derived from the cell walls of Gram-negative bacteria such as Escherichia coli, is currently a problematic pyrogen. Various studies have been conducted regarding the removal of pyrogens, and attempts have been made to remove them using activated carbon, ion exchange resins, and various separation membranes, but they have not yet reached the level of practical use. That is, these adsorbents have low selectivity for pyrogen, and a satisfactory amount of adsorption and removal cannot be obtained. Furthermore, there is also the problem of impurity elution during the adsorbent synthesis process, so it is currently impossible to actually use it.
【0003】0003
【発明の解決しようとする課題】本発明は上記のごとき
従来技術の欠点に鑑み、パイロジェンの選択性が高く、
十分な吸着除去量を有し、合成過程の不純物溶出の問題
がない発熱物質吸着剤を得ることを目的とする。Problems to be Solved by the Invention In view of the above-mentioned drawbacks of the prior art, the present invention provides high pyrogen selectivity,
The object of the present invention is to obtain a pyrogen adsorbent that has a sufficient amount of adsorption and removal and does not have the problem of impurity elution during the synthesis process.
【0004】0004
【課題を解決するための手段】本発明者らは、従来より
LPSの燐酸基がアミノ基と相互作用すること、アミノ
基のうちで一級アミノ基型がアニオン性物質との相互作
用が最も弱く、LPSに対する選択性が高いこと、また
アミノ基が疎水性基の末端に結合している場合、LPS
の燐酸基及び疎水基がともに相互作用して高度な選択性
と吸着能力をもたらし、さらにシリカゲルがその製造過
程で焼結操作を伴うため生体反応性の異物が含まれず輸
液等の処理に適していることを見いだし、この知見に基
ずき本発明を完成するに至った。[Means for Solving the Problem] The present inventors have conventionally discovered that the phosphoric acid group of LPS interacts with the amino group, and that among the amino groups, the primary amino group type has the weakest interaction with anionic substances. , the selectivity for LPS is high, and when the amino group is bonded to the end of the hydrophobic group, LPS
The phosphoric acid groups and hydrophobic groups of silica gel interact with each other, resulting in high selectivity and adsorption ability.Furthermore, since silica gel involves a sintering operation during its manufacturing process, it does not contain bioreactive foreign substances and is suitable for processing such as infusions. Based on this knowledge, the present invention was completed.
【0005】即ち本発明はシリカゲルにアミノ基と疎水
基を有する官能基を結合させてなる発熱物質吸着剤、特
に該シリカゲルが多孔質体である発熱物質吸着剤を提供
することである。That is, an object of the present invention is to provide a pyrogen adsorbent comprising silica gel bonded with a functional group having an amino group and a hydrophobic group, particularly a pyrogen adsorbent in which the silica gel is porous.
【0006】本発明に用いられるシリカゲルは通常の焼
結法により得られるシリカゲルであり粒状、破砕状のい
ずれの形態であってもよい。また多孔質構造を有するシ
リカゲルの場合、吸着に関与する表面積が大きく特に好
ましい。The silica gel used in the present invention is obtained by a normal sintering method and may be in either granular or crushed form. Furthermore, silica gel having a porous structure is particularly preferable because it has a large surface area involved in adsorption.
【0007】本発明におけるアミノ基と疎水基を有する
官能基とは、一級、二級、三級または四級のアミノ基を
一個以上含有して、かつアルキル基、アリール基、フェ
ニル基等の炭化水素基を有していればよくアミノエチル
基、アミノプロピル基、アミノブチル基、アミノヘキシ
ル基等のモノアミノアルキル基、ジアミノエチル基、ジ
アミノプロピル基、ジアミノブチル基、ジアミノヘキシ
ル基等のジアミノアルキル基、等が挙げられる。またこ
れらのアミノ基は該疎水基のどの部分に結合していても
良いが、好ましくはこれらアミノ基のうちの少なくとも
一個は末端に結合しているものがよい。また該疎水基に
エーテル結合、アミド結合、エステル結合等を含んでい
ても良い。シリカゲルに含有されるアミノ基は、好まし
くは0.01meq/g以上、更に好ましくは0.1m
eq/g以上である。[0007] In the present invention, the functional group having an amino group and a hydrophobic group refers to a functional group containing one or more primary, secondary, tertiary or quaternary amino groups, and containing carbonized alkyl groups, aryl groups, phenyl groups, etc. Monoaminoalkyl groups such as aminoethyl, aminopropyl, aminobutyl, and aminohexyl groups; diaminoalkyl groups such as diaminoethyl, diaminopropyl, diaminobutyl, and diaminohexyl groups; Groups, etc. These amino groups may be bonded to any part of the hydrophobic group, but preferably at least one of these amino groups is bonded to the terminal. Further, the hydrophobic group may contain an ether bond, an amide bond, an ester bond, etc. The amino group contained in the silica gel is preferably 0.01 meq/g or more, more preferably 0.1 meq/g.
It is equal to or higher than eq/g.
【0008】これらのアミノ基と疎水基を有する官能基
をシリカゲルに導入する方法は、通常シランカップリン
グ反応を用いる。即ち上記アミノ基と疎水基を有するシ
ランカップリング剤、例えばジエチルアミノプロピルト
リエトキシシラン、アミノベンジルトリエトキシシラン
、ジエチルアミノエチルフェニルトリエトキシシラン等
のシランカップリング剤を脱水溶媒中に分散したシリカ
ゲルに添加すれば室温で速やかに反応する。反応が終了
した後濾過、遠心分離等の方法でシリカゲルを分離し、
蒸留水及び適当な有機溶媒でゲルを洗浄する。このよう
にして調整された吸着剤は、緩衝液及び食塩水等で充分
洗浄した後吸着に用いられる。[0008] A method for introducing these functional groups having an amino group and a hydrophobic group into silica gel usually uses a silane coupling reaction. That is, a silane coupling agent having the above amino group and a hydrophobic group, such as diethylaminopropyltriethoxysilane, aminobenzyltriethoxysilane, diethylaminoethyl phenyltriethoxysilane, etc., is added to silica gel dispersed in a dehydrated solvent. It reacts quickly at room temperature. After the reaction is completed, the silica gel is separated by filtration, centrifugation, etc.
Wash the gel with distilled water and a suitable organic solvent. The adsorbent thus prepared is used for adsorption after being sufficiently washed with a buffer solution, saline, etc.
【0009】[0009]
【作用】本発明により、注射液、透析液、輸液、培養薬
品等に含まれる発熱物質の吸着技術が確立された。その
メカニズムは明かではないが、吸着剤の有するアミノ基
及びそれに結合している疎水基によってLPSが選択的
に吸着されるものと考えられる。[Operation] According to the present invention, a technology for adsorbing pyrogens contained in injection solutions, dialysates, infusions, culture chemicals, etc. has been established. Although the mechanism is not clear, it is thought that LPS is selectively adsorbed by the amino group of the adsorbent and the hydrophobic group bonded thereto.
【0010】0010
【発明の効果】本発明の発熱物質吸着剤は、(1)発熱
物質以外の塩類、アミノ酸、有用タンパク質を吸着する
ことなく選択性が高い(2)発熱物質の吸着量及び吸着
速度が大きい(3)吸着剤は生体適合性を有するなどの
優れた効果を奏する。Effects of the Invention The pyrogen adsorbent of the present invention (1) has high selectivity without adsorbing salts, amino acids, and useful proteins other than pyrogens; (2) has a large adsorption amount and adsorption rate of pyrogens ( 3) The adsorbent has excellent effects such as biocompatibility.
【0011】[0011]
【実施例】以下実施例にしたがって、本発明をさらに詳
しく説明するが、本発明は、これら実施例に限られるも
のではない。なお発熱物質の定量測定は生化学工業社(
株式会社)製エンドトキシン定量試薬キットによるリム
ルス発色テストを行った。
製造例1
カラムクロマトグラフィー用全多孔質球状シリカゲル(
15〜40μm)5gを良く乾燥し、脱水したTHF1
00cc中に分散する。これにジエチルアミノプロピル
トリエトキシシラン1.4gを加え窒素雰囲気下で2時
間反応させた後、濾過し蒸留水及びエタノールで充分洗
浄する。得られたゲルを充分乾燥し、滴定によってアミ
ノ基含有率を測定すると0.84meq/gであった。EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited to these Examples. The quantitative measurement of pyrogens was conducted by Seikagaku Kogyo Co., Ltd. (
A limulus color development test was conducted using an endotoxin quantitative reagent kit manufactured by Co., Ltd.). Production Example 1 Fully porous spherical silica gel for column chromatography (
15-40μm) well dried and dehydrated THF1
Dispersed in 00cc. To this was added 1.4 g of diethylaminopropyltriethoxysilane and the mixture was reacted for 2 hours under a nitrogen atmosphere, followed by filtration and thorough washing with distilled water and ethanol. The obtained gel was sufficiently dried and the amino group content was measured by titration and found to be 0.84 meq/g.
【0012】製造例2
製造例1に於てジエチルアミノプロピルトリエトキシシ
ランの代わりにアミノベンジルトリエトキシシラン1g
を用いて同様に合成した。得られたゲルのアミノ基含有
率は0.54meq/gであった。Production Example 2 In Production Example 1, 1 g of aminobenzyltriethoxysilane was used instead of diethylaminopropyltriethoxysilane.
It was synthesized in the same manner using The amino group content of the obtained gel was 0.54 meq/g.
【0013】製造例3
製造例1に於てジエチルアミノプロピルトリエトキシシ
ランの代わりにジエチルアミノヘキシルトリエトキシシ
ラン2gを用いて同様に合成した。得られたゲルのアミ
ノ基含有率は1.04meq/gであった。Production Example 3 Synthesis was carried out in the same manner as in Production Example 1 except that 2 g of diethylaminohexyltriethoxysilane was used in place of diethylaminopropyltriethoxysilane. The amino group content of the obtained gel was 1.04 meq/g.
【0014】実施例1
製造例1,2及び3で得られた吸着剤それぞれ1gを、
ステンレスカラム(内径4.5mm、長さ150mm)
に充填し30mmol燐酸緩衝液100ml、1mol
食塩水150mlをそれぞれ0.5ml/minで通液
したのち発熱物質の含まれない蒸留水で完全に食塩を洗
浄する、その後大腸菌由来のエンドトキシン(生化学工
業社(株)製LPSコントロール E、coli
055−B5)1ng/mlに調整した蒸留水25ml
を、流速0.5ml/minで通液しカラム出口より補
集した蒸留水中に含まれるエンドトキシンを定量した。Example 1 1 g of each of the adsorbents obtained in Production Examples 1, 2, and 3 was
Stainless steel column (inner diameter 4.5mm, length 150mm)
Filled with 100ml of 30mmol phosphate buffer, 1mol
After passing 150 ml of saline at a rate of 0.5 ml/min, the salt is completely washed away with pyrogen-free distilled water, and then endotoxin derived from Escherichia coli (LPS control manufactured by Seikagaku Kogyo Co., Ltd.) is removed.
055-B5) 25ml of distilled water adjusted to 1ng/ml
was passed through the column at a flow rate of 0.5 ml/min, and the endotoxin contained in the distilled water collected from the column outlet was quantified.
【0015】実施例2
L−イソロイシン、L−ロイシン、L−リジン、L−メ
チオニン、L−フェニルアラニン、L−スレオニン、L
−バリン、L−トリプトファンそれぞれ0.1g/1を
含む蒸留水を大腸菌由来のエンドトキシン(生化学工業
社(株)製LPSコントロール E、coli 0
55−B5)で1ng/mlに調整した溶液100ml
中に、製造例1及び2で得られた吸着剤それぞれ1gを
、分散し撹拌しながら室温で8時間吸着させる。Example 2 L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L
- Distilled water containing 0.1 g/1 each of valine and L-tryptophan was added to Escherichia coli-derived endotoxin (LPS control manufactured by Seikagaku Corporation) E. coli 0
100 ml of solution adjusted to 1 ng/ml with 55-B5)
1 g of each of the adsorbents obtained in Production Examples 1 and 2 was dispersed therein and allowed to adsorb at room temperature for 8 hours while stirring.
【0016】吸着処理した上澄み液のエンドトキシン濃
度及びアミノ酸濃度を測定しエンドトキシン吸着率及び
アミノ酸の回収率を算出した。アミノ酸分析は、日本分
光株式会社製アミノ酸分析装置を用いた。
吸着剤
製造例1 吸着剤製造例2 吸着剤製造例
3エンドトキシン吸着率 99.5%
99.3% 99.7%アミノ酸
回収率
L−イソロイシン 99.1%
99.2% 98.9%L−ロ
イシン 97.5%
95.5% 96.8%L−リジ
ン 98.8%
94.8% 93.7%L−メチ
オニン 99.5%
96.8% 94.8%L−フェニル
アラニン 96.9% 93.6
% 96.5%L−スレオニン
98.2% 98.8%
94.4%L−バリン
99.0% 97.5%
97.1%L−トリプトファン
95.7% 96.7%
94.7%The endotoxin concentration and amino acid concentration of the adsorbed supernatant were measured, and the endotoxin adsorption rate and amino acid recovery rate were calculated. For amino acid analysis, an amino acid analyzer manufactured by JASCO Corporation was used. Adsorbent production example 1 Adsorbent production example 2 Adsorbent production example 3 Endotoxin adsorption rate 99.5%
99.3% 99.7% Amino acid recovery L-isoleucine 99.1%
99.2% 98.9%L-leucine 97.5%
95.5% 96.8%L-lysine 98.8%
94.8% 93.7%L-Methionine 99.5%
96.8% 94.8%L-phenylalanine 96.9% 93.6
% 96.5% L-threonine
98.2% 98.8%
94.4% L-valine
99.0% 97.5%
97.1% L-tryptophan
95.7% 96.7%
94.7%
【0017】実施例3
人工腎臓透析用液中に含まれるエンドトキシン濃度は1
.4ng/mlであった。この透析液500ccをそれ
ぞれ合成例1,2及び3で調整した吸着剤2gを充填し
たステンレスカラムに流速1ml/minで通液し、カ
ラムより流出した透析液中のエンドトキシン濃度を測定
した。
また吸着処理した透析液中の各種イオン濃度及び糖濃度
に変化はみられなかった。Example 3 The endotoxin concentration contained in the artificial kidney dialysis fluid was 1
.. It was 4ng/ml. 500 cc of this dialysate was passed through a stainless steel column filled with 2 g of the adsorbent prepared in Synthesis Examples 1, 2, and 3 at a flow rate of 1 ml/min, and the endotoxin concentration in the dialysate flowing out from the column was measured. Furthermore, no changes were observed in the concentrations of various ions and sugars in the adsorbed dialysate.
Claims (2)
からなる発熱物質吸着剤。1. A pyrogen adsorbent made of silica gel having an amino group and a hydrophobic group.
記載の発熱物質吸着剤。Claim 2: Claim 1, wherein the silica gel is a porous material.
Pyrogen adsorbent as described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3103228A JPH04256434A (en) | 1991-02-06 | 1991-02-06 | Pyrogen adsorbent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3103228A JPH04256434A (en) | 1991-02-06 | 1991-02-06 | Pyrogen adsorbent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04256434A true JPH04256434A (en) | 1992-09-11 |
Family
ID=14348617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3103228A Pending JPH04256434A (en) | 1991-02-06 | 1991-02-06 | Pyrogen adsorbent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04256434A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2679258A1 (en) * | 2011-02-25 | 2014-01-01 | Toray Industries, Inc. | Carrier for blood component adsorption and blood component adsorption column |
-
1991
- 1991-02-06 JP JP3103228A patent/JPH04256434A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2679258A1 (en) * | 2011-02-25 | 2014-01-01 | Toray Industries, Inc. | Carrier for blood component adsorption and blood component adsorption column |
EP2679258A4 (en) * | 2011-02-25 | 2014-07-23 | Toray Industries | Carrier for blood component adsorption and blood component adsorption column |
AU2012221057B2 (en) * | 2011-02-25 | 2015-02-19 | Toray Industries, Inc. | Carrier for blood component adsorption and blood component adsorption column |
JP5954172B2 (en) * | 2011-02-25 | 2016-07-20 | 東レ株式会社 | Blood component adsorption carrier and blood component adsorption column |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3676817B2 (en) | Novel factor IX purification method | |
US4138287A (en) | Purifying and isolating method for hepatitis virus to use in preparing vaccine | |
KR930001609B1 (en) | Seperating method and seperant | |
Hanora et al. | Capture of bacterial endotoxins using a supermacroporous monolithic matrix with immobilized polyethyleneimine, lysozyme or polymyxin B | |
JP6170148B2 (en) | Potato protein isolate | |
JP2010210497A (en) | Filler for liquid chromatography and method of separating/refining biopolymer | |
JP2022528310A (en) | Methods for Depleting or Eliminating Endotoxins from Endotoxin-Containing Supplies or Supplies That May Contain Endotoxins | |
JPH0427504B2 (en) | ||
JP2004532182A5 (en) | ||
JPS5832591B2 (en) | Purification method of urokinase | |
FI72342B (en) | FOLLOWING FOLDER ISOLERING AV BAKTERIELUCIFERAS OCH AFFINITETSHARTS ANVAENDBART DAERI | |
US9505850B2 (en) | Endotoxin adsorbent | |
JPH04256434A (en) | Pyrogen adsorbent | |
Yavuz et al. | Dye affinity hollow fibers for albumin purification | |
JPH01171638A (en) | Adsorbent for serum amyloid a protein | |
Malik et al. | Development of bovine serum albumin-bonded silica as a chiral stationary phase and its application in quantitative direct enantiomeric resolution | |
JPH0977790A (en) | Adsorbent for antibody to glycolipid | |
RU2529221C1 (en) | Method of removing endotoxins from aqueous solutions | |
RU2641924C1 (en) | Sorption material, method of its production and method of its application | |
TW200927254A (en) | Antibody production method | |
JP5389342B2 (en) | Adsorption carrier and production method of adsorption carrier | |
Jin et al. | Novel method for human serum albumin adsorption/separation from aqueous solutions and human plasma with Cibacron Blue F3GA-Zn (II) attached microporous affinity membranous capillaries | |
Xianfang et al. | Supported chitosan-dye affinity membranes and their protein adsorption | |
JP2000189792A (en) | Adsorbent of lipopolysaccharide and adsorbing and removing method of lipopolysaccharide | |
JPH02204500A (en) | Insoluble carrier using antimicrobial peptide derived from horseshoe crab corpuscular membrane as ligand |